The transcription factors T-bet and GATA3 are important reciprocal determinants of Th1 and Th2 T helper cell differentiation. Recent evidence suggests that these factors may affect airway immunopathology in asthma.
Differentiation of Th1 and Th2 Cells
The major determinant of whether an activated naïve CD4 + T helper cell develops into a Th1 or Th2 effector/memory cell is the presence of IL-12 or IL-4, respectively. In addition, IFNγ γ and IL-18 can potentiate Th1 development. The molecular events that programme the Th1 or Th2 phenotype have been extensively studied in vitro and by gene deletion in mice [2] . Although it was suggested that T-bet expression may be stochastic [9] , it has recently been shown that T-bet is upregulated in lymphoid and myeloid cells by IFNγ γ in a Stat1-dependent manner within 6 hours, and this early T-bet activation is Stat4 independent [10] . However, Grogan et al. [5] showed that at 72 hours T-bet upregulation in Th1 was not seen in Stat4-deficient mice, though this could be an indirect effect via IFNγ γ [6]. GATA3 expression can occur in the absence of Stat6, but Stat6-dependent pathways upregulate expression [7] . Taken together these data suggest that initial Th1 differentiation is dependent on IFNγ γ-induced T-bet expression, whilst GATA3 will direct Th2 differentiation. Full expression of a polarised immune response may require expansion, selective survival and stabilisation of cytokine mRNA of Th1 cells via IL-12-induced Stat4, with amplification of IFNγ γ production by IL-18, or Th2 cells via IL-4-induced Stat6 [2] . A key part of Th1 development is retention of IL-12Rβ β2 -and hence IL-12 responsiveness -whilst Th2 cells lose IL-12Rβ β2. T-bet was found to induce IL-12Rβ β2 expression [9] , so that part of the phenotype resulting from T-bet deficiency may result from a loss of ability to retain IL-12 responsiveness. These control elements are summarised in Figure 1 . Whether the same control mechanisms apply in human cells remains to be fully confirmed. [18] , exogenous IL-12 had no effect on asthma symptoms or lung function despite reducing blood and sputum eosinophilia [19] . In animal models most workers report that transfer of Th1 cells into the airways can exacerbate Th2-mediated lung pathology, and Th1 cells can themselves cause disease [20] , so switching on T-bet in asthma might not be beneficial.
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The confirmation of T-bet and GATA3 as Th1 and Th2 control factors in vitro and in vivo is of great interest. Whether this will allow the therapeutic manipulation of the immune response that has been a goal ever since the description of the Th1/Th2 dichotomy is uncertain, but these are tantalising targets.
